Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

N-Able Maintains Analyst Confidence Despite Executive Share Sale

Robert Sasse by Robert Sasse
September 7, 2025
in Analysis, Insider Trading, Tech & Software
0
N-Able Stock
0
SHARES
186
VIEWS
Share on FacebookShare on Twitter

Market experts continue to endorse N-Able shares with a “Moderate Buy” consensus recommendation, even as the company’s Executive Vice President recently divested a substantial portion of his holdings. This divergence between insider action and analyst outlook presents investors with a compelling puzzle.

Strong Quarterly Performance Underpins Optimism

The bullish stance from Wall Street follows N-Able’s impressive second-quarter results for fiscal 2025. The cloud software specialist reported earnings per share of $0.11, significantly surpassing the $0.09 consensus estimate. Revenue reached $131.25 million, exceeding projections and demonstrating robust year-over-year growth of 9.9 percent.

Five equity researchers covering the company maintain positive ratings, with their collective price target of $9.31 suggesting approximately 18 percent upside from current trading levels. Individual forecasts range from $8.50 to $10.00 per share.

Insider Transaction and Revised Estimates

Despite this optimism, investors noted a notable insider transaction in mid-August. Michael I. Adler, an executive vice president at the company, sold shares valued at nearly $245,000. Such disposals by senior management often attract scrutiny as potential signals about a company’s prospects.

Should investors sell immediately? Or is it worth buying N-Able?

Additionally, analysts have slightly tempered their full-year expectations over the past month. The consensus EPS estimate for fiscal 2025 has been adjusted downward from $0.15 to $0.14.

Strategic Expansion and Maintained Guidance

N-Able continues to execute its growth strategy, particularly in the cybersecurity domain. The November 2024 acquisition of Adlumin enhanced its offerings with cloud-native XDR and MDR solutions. This strategic move is anticipated to contribute to annual recurring revenue (ARR) and cash flow growth by the fourth quarter of 2025.

Management has reaffirmed its full-year 2025 outlook, projecting revenue between $500 million and $503 million. This would represent growth of 7 to 8 percent compared to the previous year.

Upcoming Catalyst and Market Watch

The investment community now turns its attention to the upcoming Q3 2025 earnings release scheduled for November 6. This report will provide crucial insight into whether the analysts’ confidence is well-founded or if the insider’s decision to reduce exposure might indicate challenges ahead. The market will be watching closely to see which perspective proves accurate.

Ad

N-Able Stock: Buy or Sell?! New N-Able Analysis from March 25 delivers the answer:

The latest N-Able figures speak for themselves: Urgent action needed for N-Able investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

N-Able: Buy or sell? Read more here...

Tags: N-Able
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

TeamViewer Stock
Analysis

TeamViewer’s SDAX Debut Coincides With Share Price Weakness

March 25, 2026
Shell Stock
Analysis

Shell Shares Face Analyst Downgrade Following Quarterly Results

March 25, 2026
Heidelberg Materials Stock
Analysis

Heidelberg Materials Stock Gains on Strong Fundamentals

March 25, 2026
Next Post
Nurix Therapeutics Inc Stock

Nurix Therapeutics Stock Surges on Renewed Investor Confidence

PayPal Stock

Venmo Emerges as PayPal's Unexpected Growth Engine

Micron Stock

Micron Stock Surges to Record High on Strong AI Demand

Recommended

Coinbase Stock

Coinbase Expands Its Strategic Footprint Across Multiple Fronts

1 month ago
AnaptysBio Stock

AnaptysBio Shares Approach Critical Juncture as Key Events Loom

7 months ago
Origin Materials Stock

Can Origin Materials Stock Recover From Its Steep Decline?

4 months ago
Cassava Sciences Stock

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

Energiekontor Stock Gains Momentum from Policy Shifts

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Trending

TeamViewer Stock
Analysis

TeamViewer’s SDAX Debut Coincides With Share Price Weakness

by SiterGedge
March 25, 2026
0

TeamViewer's formal move to Germany's SDAX index represents more than a symbolic shift, occurring alongside a cautious...

Shell Stock

Shell Shares Face Analyst Downgrade Following Quarterly Results

March 25, 2026
Heidelberg Materials Stock

Heidelberg Materials Stock Gains on Strong Fundamentals

March 25, 2026
Glencore Stock

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

March 25, 2026
Energiekontor Stock

Energiekontor Stock Gains Momentum from Policy Shifts

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • TeamViewer’s SDAX Debut Coincides With Share Price Weakness
  • Shell Shares Face Analyst Downgrade Following Quarterly Results
  • Heidelberg Materials Stock Gains on Strong Fundamentals

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com